A multi-center, multi-country, cross-sectional study on the prevalence of ADHD in non-psychotic adult psychiatric care (ADPSYC)
- Conditions
- ADHD - hyperactivity10009841
- Registration Number
- NL-OMON38985
- Lead Sponsor
- Eli Lilly
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- Not specified
- Target Recruitment
- 240
Inclusion Criteria
- Male or female outpatients aged between 18 and 65 years attending psychiatric outpatient care
- having signed an informed consent to release information prior to any procedure
Exclusion Criteria
- Mental disability or disease state to an extent that prevents patients from
understanding the nature of the study or that prevents patients from reliably
following procedures
- Psychotic disorder at presentation or from patient*s history (schizophrenia,schizo-affective, schizophreniform, delusional disorder). Treatment with antipsychotics ,for other indications is not an exclusion criterion.
- Have previously been approached or screened for the study
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary objective of this study is to estimate the prevalence of ADHD in<br /><br>non-psychotic adults in psychiatric outpatient care as assessed by the<br /><br>Diagnostic Interview for ADHD in Adults (DIVA) instrument according to DSM-IV<br /><br>criteria.</p><br>
- Secondary Outcome Measures
Name Time Method